Through journaling and connecting with my faith, I was able to embrace everything I was thinking and feeling during colon ...

The recent FDA approval of Lazcluze plus Rybrevant for EGFR-mutant non-small cell lung cancer is a “big deal” for patients, ...

Spleen size, blood counts and symptom burden are some of the factors cancer teams take into account when selecting which of the four JAK inhibitors to treat patient with myelofibrosis.

The Food and Drug Administration (FDA) has cleared an investigational new drug application for the novel treatment, APTN-101, ...

I wrote this poem in honor of my niece who had breast cancer, who was determined to live out the rest of her life giving her ...

Christine Simonelli, BSN, RN, CCRC, OCN is amazing, and 250 words will never be enough to express my admiration.

Dr. Partow Kebriaei explains what patients can expect before, during and after an allogeneic stem cell transplant to treat ...

Wrisper would eventually be treated with the groundbreaking chimeric antigen receptor (CAR)-T cell therapy, first approved ...

Having myelodysplastic syndromes has taught me to cherish every day and to pursue the things that matter to me, like ...

Boruzu, an injectable presentation of Velcade, has been approved by the FDA for patients who either have multiple myeloma or ...

For patients with MDS, close monitoring by doctors may help determine the appropriate timing to undergo stem cell transplants ...

The Food and Drug Administration granted a fast track designation to IBI363 for patients with unresectable advanced or ...